New Cohort Discovery Tools Available to UR Researchers Via TriNetX

University of Rochester researchers can now access a new set of analytic tools and an expanded network database of over 60 million patients through TriNetX, a cohort discovery tool launched at the university last year.

Use the COVID-19 Biobank to Support Your Coronavirus Research

University of Rochester research faculty and staff can request access to thousands of COVID-19-positive and -negative blood specimens and associated, de-identified clinical data through the COVID-19 Biobank. See what the Biobank has to offer and submit a request today.  

UR CTSI Broadens Patient Cohort Discovery Capability at UR Through ACT Network

University of Rochester researchers can now query de-identified data from 125 million patients across the country to validate the feasibility of their clinical trials and find collaborators for multi-site trials through the ACT Network.

COVID-19 Biobank Helps Researchers Share Patients’ Samples

The dedicated biorepository will safely collect and store serum, plasma and immune cell samples from COVID-19-positive and -negative patients. Researchers will be able to request access to the samples, which will be linked to the patients’ de-identified clinical data.

UR CTSI Offers New Electronic Medical Record Cohort Discovery Tool

TriNetX provides URMC researchers with access to longitudinal clinical data in near-real-time and uses state-of-the-art analytics to identify potential study participants based on specific study criteria.